These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 36745269)

  • 1. Neuroprotective Roles of Apelin-13 in Neurological Diseases.
    Zhang Y; Jiang W; Sun W; Guo W; Xia B; Shen X; Fu M; Wan T; Yuan M
    Neurochem Res; 2023 Jun; 48(6):1648-1662. PubMed ID: 36745269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apelin/APJ system: an emerging therapeutic target for neurological diseases.
    Li A; Zhao Q; Chen L; Li Z
    Mol Biol Rep; 2023 Feb; 50(2):1639-1653. PubMed ID: 36378421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective gain of Apelin/APJ system.
    Zhou JX; Shuai NN; Wang B; Jin X; Kuang X; Tian SW
    Neuropeptides; 2021 Jun; 87():102131. PubMed ID: 33640616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection of apelin and its signaling pathway.
    Cheng B; Chen J; Bai B; Xin Q
    Peptides; 2012 Sep; 37(1):171-3. PubMed ID: 22820556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats.
    Xu W; Li T; Gao L; Zheng J; Yan J; Zhang J; Shao A
    J Neuroinflammation; 2019 Dec; 16(1):247. PubMed ID: 31791369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis.
    Wu L; Chen L; Li L
    Clin Chim Acta; 2017 Mar; 466():78-84. PubMed ID: 28025030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apelin/APJ system in inflammation.
    Wang X; Zhang L; Li P; Zheng Y; Yang Y; Ji S
    Int Immunopharmacol; 2022 Aug; 109():108822. PubMed ID: 35605524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apelin receptor homodimer inhibits apoptosis in vascular dementia.
    Wang D; Wang Y; Shan M; Chen J; Wang H; Sun B; Jin C; Li X; Yin Y; Song C; Xiao C; Li J; Wang T; Cai X
    Exp Cell Res; 2021 Oct; 407(1):112739. PubMed ID: 34343559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple roles of apelin/APJ system in eye diseases.
    Luo J; Zhao Q; Li Z; Chen L
    Peptides; 2022 Jun; 152():170767. PubMed ID: 35181348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.
    Lv D; Li H; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):527-33. PubMed ID: 23588025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease.
    Wan T; Fu M; Jiang Y; Jiang W; Li P; Zhou S
    Neurochem Res; 2022 Feb; 47(2):205-217. PubMed ID: 34518975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apelin/Apelin Receptor System: Molecular Characteristics, Physiological Roles, and Prospects as a Target for Disease Prevention and Pharmacotherapy.
    Kinjo T; Higashi H; Uno K; Kuramoto N
    Curr Mol Pharmacol; 2021; 14(2):210-219. PubMed ID: 32484774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of apelin on ischemia/reperfusion injury.
    Yang Y; Lv SY; Lyu SK; Wu D; Chen Q
    Peptides; 2015 Jan; 63():43-6. PubMed ID: 25447414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin/APJ system: a promising therapy target for hypertension.
    Wu D; He L; Chen L
    Mol Biol Rep; 2014 Oct; 41(10):6691-703. PubMed ID: 24990699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
    Chen X; Bai B; Tian Y; Du H; Chen J
    J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The functional role of endogenous APJ agonists; Apelin and Elabela/Toddler in cardiovascular diseases].
    Sato T; Kuba K
    Nihon Yakurigaku Zasshi; 2019; 153(4):172-178. PubMed ID: 30971657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin/APJ signaling in hypoxia-related diseases.
    He L; Xu J; Chen L; Li L
    Clin Chim Acta; 2015 Dec; 451(Pt B):191-8. PubMed ID: 26436483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.
    Medhurst AD; Jennings CA; Robbins MJ; Davis RP; Ellis C; Winborn KY; Lawrie KW; Hervieu G; Riley G; Bolaky JE; Herrity NC; Murdock P; Darker JG
    J Neurochem; 2003 Mar; 84(5):1162-72. PubMed ID: 12603839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.
    O'Carroll AM; Lolait SJ; Harris LE; Pope GR
    J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.